Target Details
| UniProt AC | P15056 |
|---|---|
| Gene Symbol | BRAF |
| Protein Name | Serine/threonine-protein kinase B-raf |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,643
- Clinical molecules 78
- Avg pChEMBL 7.81
KEGG Pathways (44)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Bladder cancer
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemokine signaling pathway
- Chronic myeloid leukemia
- Colorectal cancer
- Cushing syndrome
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Insulin signaling pathway
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanoma
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Progesterone-mediated oocyte maturation
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Renal cell carcinoma
- Serotonergic synapse
- Thyroid cancer
- Vascular smooth muscle contraction
- cAMP signaling pathway
- mTOR signaling pathway
Associated Diseases (10)
Active Molecules (2,643)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
QIKQYKNREYQNEP
|
9.0 | IC50 | 2 | — | |
QPOWGPGOTGCBQP
|
9.0 | IC50 | 2 | — | |
RZKVDWJDQSXNFH
|
9.0 | IC50 | 2 | — | |
SHBMQJJYZPYFJY
|
9.0 | IC50 | 2 | — | |
TVJCAVBGPYIKNG
|
9.0 | IC50 | 2 | — | |
UUWPEGPXUJHHFO
|
9.0 | IC50 | 2 | — | |
WCSQDCPCGRYUND
|
9.0 | IC50 | 2 | — | |
WRVIULGXAIWQCU
|
9.0 | IC50 | 2 | — | |
YMLMZIAYGCZUDE
|
9.0 | IC50 | 2 | — | |
YQMMKGYFCJXQJL
|
9.0 | IC50 | 2 | — | |
BASYRTWYANPNGP
|
8.9 | IC50 | 2 | — | |
PALWFNXLARYKAG
|
8.9 | IC50 | 2 | — | |
USJAEJZDPVWJNJ
|
8.9 | IC50 | 2 | — | |
WQNJLMVKMKGYHJ
|
8.9 | IC50 | 2 | — | |
XKGGRFGDCYJJJU
|
8.9 | IC50 | 2 | — | |
BRHVOQCQIFRMBJ
|
8.9 | IC50 | 2 | — | |
JBZRRAJGJPIOCP
|
8.9 | IC50 | 2 | — | |
VUXHDBFZTVRSRN
|
8.9 | IC50 | 3 | — | |
AUZAPTUBDQMDLQ
|
8.9 | IC50 | 2 | — | |
FOGNLUOMZWHCJL
|
8.9 | IC50 | 2 | — | |
RXHCQJSVKSFKKA
|
8.9 | IC50 | 2 | — | |
YFCGZSBLRQTQCQ
|
8.9 | IC50 | 2 | — | |
CKRMDSYNVASFQQ
|
8.9 | IC50 | 3 | — | |
CSLYSZPPFQPIIR
|
8.9 | IC50 | 2 | — | |
GQDKSXFQIIYQAD
|
8.9 | IC50 | 2 | — | |
JTEANFGHGBODHM
|
8.9 | IC50 | 2 | — | |
KTVVJONHPNVZMG
|
8.9 | IC50 | 2 | — | |
LFYJXEXEFATBPN
|
8.9 | IC50 | 2 | — | |
LPNQQFUIZZVMMW
|
8.9 | IC50 | 2 | — | |
LXRREFDETBYDJJ
|
8.9 | IC50 | 2 | — | |
LZXNILKTKRIYAA
|
8.9 | IC50 | 2 | — | |
NCMZDKQKMPBEIV
|
8.9 | IC50 | 2 | — | |
NNLHMYBDMYXIKH
|
8.9 | IC50 | 2 | — | |
NQSNNAVTPSOCHY
|
8.9 | IC50 | 3 | — | |
PCPBCWBSNIULDF
|
8.9 | IC50 | 2 | — | |
PVHIKHBFEDYUHJ
|
8.9 | IC50 | 2 | — | |
SDTMEOJAYBOKRA
|
8.9 | IC50 | 2 | — | |
SWWUULLUNIUGEY
|
8.9 | IC50 | 2 | — | |
UFSSCDAODYJAIS
|
8.9 | IC50 | 2 | — | |
URECZFRBORHDEQ
|
8.9 | IC50 | 2 | — | |
WQAAGADGLQVCDN
|
8.9 | IC50 | 2 | — | |
WUENUYHMSVASQE
|
8.9 | IC50 | 2 | — | |
ZHOGCJWDDJEERU
|
8.9 | IC50 | 2 | — | |
ITCUYRPGRFYIBZ
|
8.9 | IC50 | 2 | — | |
ISYANDALIHYXTG
|
8.9 | IC50 | 2 | — | |
RTBNNSJDMQCXGZ
|
8.9 | IC50 | 2 | — | |
AHSWXYMNZRQFGL
|
8.9 | IC50 | 2 | — | |
AXYWWZQSJHAPEU
|
8.9 | IC50 | 2 | — | |
CASQHERFADFEPM
|
8.9 | IC50 | 2 | — | |
DZVUMQLQVYBRHR
|
8.9 | IC50 | 2 | — |